We are live on !
Find out more
EP
Elkfork Partners Portfolio holdings
AUM
$4.11B
Turnover
7.52%
1-Year Est. Return
5.26%
This Fund
S&P 500
This Quarter Est. Return
+1.27%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.11B
AUM Growth
+$18.6M
(+0.45%)
Cap. Flow
-$4.43M
Cap. Flow % of AUM
Cap. Flow %
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
26.54%
Holding
1,091
New
44
Increased
380
Reduced
255
Closed
38
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pluralsight, Inc. Class A Common Stock
PS
|
+$14.6M |
| 2 |
Microsoft
MSFT
|
+$13.8M |
| 3 |
Citigroup
C
|
+$11.7M |
| 4 |
Amazon
AMZN
|
+$10.5M |
| 5 |
Splunk Inc
SPLK
|
+$9.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$14.5M |
| 2 |
Wells Fargo
WFC
|
+$12.3M |
| 3 |
Fortinet
FTNT
|
+$12.2M |
| 4 |
Cognizant
CTSH
|
+$11.4M |
| 5 |
MetLife
MET
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.89% |
| 2 | Financials | 15.38% |
| 3 | Consumer Discretionary | 12.11% |
| 4 | Healthcare | 10.73% |
| 5 | Communication Services | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1026
Sarepta Therapeutics
SRPT
$1.96B
| $22K | ﹤0.01% |
286
+88
| +44% | +$10.4K |
2018 Q4
3 quarters
|
|
|
STSA
1027
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $22K | ﹤0.01% |
+1,474
| New | +$22.9K |
2019 Q3
0 quarters
|
|
1028
MACOM Technology Solutions
MTSI
$18.2B
| $21K | ﹤0.01% |
+990
| New | +$19.3K |
2019 Q3
0 quarters
|
|
|
RETA
1029
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $21K | ﹤0.01% |
264
| – | – |
2018 Q4
3 quarters
|
|
1030
BlackBerry
BB
$4.79B
| $20K | ﹤0.01% |
3,978
+34
| +0.9% | +$239 |
2018 Q3
4 quarters
|
|
1031
Kura Oncology
KURA
$883M
| $20K | ﹤0.01% |
1,298
| – | – |
2018 Q1
6 quarters
|
|
1032
Avantor
AVTR
$10.7B
| $19K | ﹤0.01% |
+1,320
| New | +$22.4K |
2019 Q3
0 quarters
|
|
1033
DELISTED
Verint Systems
VRNT
| $19K | ﹤0.01% |
879
| – | – |
2018 Q4
3 quarters
|
|
1034
DELISTED
Altair Engineering Inc
ALTR
| $19K | ﹤0.01% |
560
| – | – |
2018 Q4
3 quarters
|
|
|
MRTX
1035
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $19K | ﹤0.01% |
242
| – | – |
2019 Q1
2 quarters
|
|
1036
CareDx
CDNA
$4.65B
| $18K | ﹤0.01% |
+816
| New | +$22.6K |
2019 Q3
0 quarters
|
|
1037
Dianthus Therapeutics
DNTH
$4.76B
| $17K | ﹤0.01% |
105
| – | – |
2018 Q2
5 quarters
|
|
1038
SAP
SAP
$266B
| $16K | ﹤0.01% |
132
-1,694
| -93% | -$210K |
2016 Q4
11 quarters
|
|
1039
ICL Group
ICL
$5.67B
| $15K | ﹤0.01% |
3,322
| – | – |
2018 Q4
3 quarters
|
|
1040
Nutanix
NTNX
$17.7B
| $15K | ﹤0.01% |
588
| – | – |
2018 Q4
3 quarters
|
|
1041
Arch Capital
ACGL
$35.3B
| $14K | ﹤0.01% |
330
-10,604
| -97% | -$418K |
2019 Q2
1 quarter
|
|
1042
Box
BOX
$5.93B
| $14K | ﹤0.01% |
836
| – | – |
2018 Q4
3 quarters
|
|
1043
Denali Therapeutics
DNLI
$3.08B
| $14K | ﹤0.01% |
918
| – | – |
2018 Q4
3 quarters
|
|
1044
Huckleberry.ai, Inc. Class B Common Stock
HUCK
$141M
| $14K | ﹤0.01% |
880
| – | – |
2018 Q4
3 quarters
|
|
1045
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $12K | ﹤0.01% |
1,320
| – | – |
2019 Q2
1 quarter
|
|
|
OBSV
1046
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $12K | ﹤0.01% |
1,386
| – | – |
2018 Q2
5 quarters
|
|
|
ECOM
1047
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $12K | ﹤0.01% |
1,298
| – | – |
2018 Q4
3 quarters
|
|
1048
DELISTED
Akero Therapeutics
AKRO
| $11K | ﹤0.01% |
484
| – | – |
2019 Q2
1 quarter
|
|
1049
SoundThinking
SSTI
$110M
| $11K | ﹤0.01% |
476
| – | – |
2018 Q4
3 quarters
|
|
1050
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.3B
| $10K | ﹤0.01% |
112
| – | – |
2017 Q3
8 quarters
|
|
Similar funds
GHCM
FCM
NA
MCIM
TAM
TAM
RCM
Elkfork Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Elkfork Partners held 1,091 positions worth $4.11B, up 0.45% from $4.09B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Elkfork Partners's Q3 2019 filing shows 44 new, 380 increased, 255 reduced and 38 closed positions. Its largest new stake was TSMC: 39,844 shares worth $1.85M. The largest sale was Centene, an estimated $14.5M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Elkfork Partners's largest Q3 2019 buy was TSMC: 39,844 shares worth $1.85M.
- Elkfork Partners added most to Pluralsight, Inc. Class A Common Stock in Q3 2019, an estimated $14.6M increase.
- Elkfork Partners's biggest Q3 2019 reduction was Centene, cutting an estimated $14.5M.
- Elkfork Partners fully exited Service Properties Trust in Q3 2019, selling an estimated $8.05M.
- Elkfork Partners's ten largest holdings make up 27% of its $4.11B portfolio in Q3 2019.
- Elkfork Partners opened 44 new positions and closed 38 in Q3 2019.
- Elkfork Partners's portfolio value rose 0.45% quarter-over-quarter to $4.11B.
Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.